Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02069015 · ClinicalTrials.gov registry record · NA

Achieving Blood Pressure Control Through Enhanced Discharge

A NA study of Hypertension, sponsored by Wayne State University.

Completed
Registry status
NA
Development phase
139
Enrollment target
1
Study location

NCT02069015: Completed NA study of Hypertension, sponsored by Wayne State University.

NCT02069015 is a NA study of Hypertension that has completed, run by Wayne State University. The registered enrollment target is 139 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02069015, a NA study of Hypertension, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
NA
Development phase
139 participants
Enrollment target
1
Study location

Study Summary

The primary aim of the study is to determine if enhanced discharge from the emergency department will improve blood pressure control and self-care management. Enhanced discharge will include a hypertension intervention delivered by a touch-screen kiosk over a three month period.

Primary Outcome

Systolic Blood Pressure (SDB) at 180 days post-discharge

Conditions Studied

Interventions

  • BEHAVIORAL Patient education

Study Locations (1)

Michigan

  • Detroit Receiving Hospital Emergency Department - Detroit

Trial Details

FieldValue
Enrollment Target 139 participants
Start Date 2013-10
Est. Completion 2016-06
Phase NA
Wayne State University

163 total trials

What the finished NCT02069015 record still lists

NCT02069015 is an interventional study that assigns participants to a tested intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Patient education is the first listed.

NCT02069015 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT02069015 about?

NCT02069015 is a clinical study titled "Achieving Blood Pressure Control Through Enhanced Discharge". The primary aim of the study is to determine if enhanced discharge from the emergency department will improve blood pressure control and self-care management. Enhanced discharge will include a hypertension intervention delivered by a touch-screen kiosk over a three month period.

What is the current status of trial NCT02069015?

This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2013-10. Estimated completion is 2016-06.

What conditions does trial NCT02069015 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT02069015?

The interventions under investigation include: Patient education (BEHAVIORAL).

Who is sponsoring clinical trial NCT02069015?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02069015 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02069015's enrollment target sits among peer trials

139 260th of 470 higher than 211 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05645380 · 139 participants · Phase 2

    Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

  • NCT06239272 · 139 participants · Phase 1

    NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

  • NCT06252220 · 139 participants · Phase 1

    First in Human Study in Subjects With Obesity, But Otherwise Healthy

  • NCT06537128 · 139 participants · NA

    Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02069015, the US trial registry maintained by the National Library of Medicine. NCT02069015 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.